The US-based Institute for Clinical and Economic Review (ICER), England’s National Institute for Health and Care Excellence (NICE), and Canada’s Drug ...
Latest News
Today, for the 2nd year running Canada’s Drug Agency was named one of the National Capital Region's top employers for 2025.
This special designation ...
Canada’s Drug Agency is seeking knowledgeable and experienced individuals to join our expert and advisory committees.
Our annual call for nominations i ...
On Rare Disease Day — a global event dedicated to raising awareness for the millions of people living with rare diseases — Canada’s Drug Agency has ...
Leaders of 3 health technology assessment organizations convene working group and steering committee to critically and independently research new ...
The 2025 call for nominations to join expert and advisory committees at Canada’s Drug Agency will be open from March 3 to March 31, 2025.
These ...
Upcoming Events
All Upcoming Events2025 Watch List: Artificial Intelligence
10th Annual Forum: Pathways to Access and Reimbursement
Information Session: 2025-2026 Funding Opportunity for Rare Disease Registry Improvement
Symposium 2024
Symposium 2024 is a 3-day hybrid event that gathers leaders from across Canada with expertise in policy, industry, health technology assessment, patient advocacy, medicine, public health, and communications. The theme of Symposium 2024 is From Disruption to Opportunity: Embracing Change in Health Care.
